Beta Bionics [BBNX] vs Artivion [AORT] Detailed Stock Comparison
Beta Bionics
NASDAQ
Loading...
Artivion
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Beta Bionics wins in 4 metrics, Artivion wins in 13 metrics, with 0 ties. Artivion appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Beta Bionics | Artivion | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -17.42 | -128.28 | Artivion |
| Price-to-Book Ratio | 3.21 | 4.61 | Beta Bionics |
| Debt-to-Equity Ratio | 2.22 | 62.81 | Beta Bionics |
| PEG Ratio | 3.90 | 0.80 | Artivion |
| EV/EBITDA | -11.82 | 47.17 | Beta Bionics |
| Profit Margin (TTM) | -94.04% | -4.43% | Artivion |
| Operating Margin (TTM) | -85.52% | 9.72% | Artivion |
| EBITDA Margin (TTM) | N/A | 9.72% | N/A |
| Return on Equity | 22.32% | -5.02% | Beta Bionics |
| Return on Assets (TTM) | -36.59% | 1.70% | Artivion |
| Free Cash Flow (TTM) | $-51.67M | $11.05M | Artivion |
| 1-Year Return | -6.51% | 55.26% | Artivion |
| Price-to-Sales Ratio (TTM) | 12.40 | 4.78 | Artivion |
| Enterprise Value | $724.61M | $2.15B | Artivion |
| EV/Revenue Ratio | 9.29 | 5.30 | Artivion |
| Gross Profit Margin (TTM) | 53.80% | 64.72% | Artivion |
| Revenue per Share (TTM) | $4 | $10 | Artivion |
| Earnings per Share (Diluted) | $-1.69 | $-0.43 | Artivion |
| Beta (Stock Volatility) | N/A | 1.67 | N/A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Beta Bionics vs Artivion Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Beta Bionics | -1.39% | 13.98% | 13.11% | 64.64% | 106.69% | -5.80% |
| Artivion | -0.73% | -0.02% | -5.24% | 33.63% | 70.05% | 46.19% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Beta Bionics | -6.51% | -6.51% | -6.51% | -6.51% | -6.51% | -6.51% |
| Artivion | 55.26% | 254.18% | 112.58% | 301.27% | 563.17% | 478.98% |
News Based Sentiment: Beta Bionics vs Artivion
Beta Bionics
News based Sentiment: POSITIVE
Beta Bionics demonstrated strong Q2 earnings, exceeding expectations, and secured a significant analyst upgrade. While insider selling is a concern, the influx of institutional investment and strategic partnership with Abbott suggest a positive trajectory for the company, making this a noteworthy month for investors.
Artivion
News based Sentiment: MIXED
October was a mixed month for Artivion, with a significant earnings beat and positive analyst revisions offset by notable insider selling and fluctuating stock performance. The combination of positive financial results and concerning insider activity creates a complex investment narrative, making it a moderately important month for investors.
Performance & Financial Health Analysis: Beta Bionics vs Artivion
| Metric | BBNX | AORT |
|---|---|---|
| Market Information | ||
| Market Cap | $1.10B | $1.98B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 803,623 | 388,190 |
| 90 Day Avg. Volume | 938,151 | 443,357 |
| Last Close | $21.95 | $40.75 |
| 52 Week Range | $8.89 - $26.66 | $21.97 - $45.07 |
| % from 52W High | -17.67% | -9.59% |
| All-Time High | $26.66 (Sep 12, 2025) | $45.07 (Aug 22, 2025) |
| % from All-Time High | -17.67% | -9.59% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.54% | 0.15% |
| Quarterly Earnings Growth | 0.80% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | -0.94% | -0.04% |
| Operating Margin (TTM) | -0.86% | 0.10% |
| Return on Equity (TTM) | 0.22% | -0.05% |
| Debt to Equity (MRQ) | 2.22 | 62.81 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $6.94 | $8.91 |
| Cash per Share (MRQ) | $5.75 | $1.13 |
| Operating Cash Flow (TTM) | $-57,461,000 | $19.65M |
| Levered Free Cash Flow (TTM) | $-54,756,000 | $-12,697,875 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Beta Bionics vs Artivion
| Metric | BBNX | AORT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -17.42 | -128.28 |
| Forward P/E | -12.39 | 171.04 |
| PEG Ratio | 3.90 | 0.80 |
| Price to Sales (TTM) | 12.40 | 4.78 |
| Price to Book (MRQ) | 3.21 | 4.61 |
| Market Capitalization | ||
| Market Capitalization | $1.10B | $1.98B |
| Enterprise Value | $724.61M | $2.15B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 9.29 | 5.30 |
| Enterprise to EBITDA | -11.82 | 47.17 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.67 |
| Book Value per Share (MRQ) | $6.94 | $8.91 |
Financial Statements Comparison: Beta Bionics vs Artivion
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BBNX | AORT |
|---|---|---|
| Revenue/Sales | $17.64M | $112.97M |
| Cost of Goods Sold | $8.67M | $39.86M |
| Gross Profit | $8.97M | $73.11M |
| Research & Development | $7.59M | $7.06M |
| Operating Income (EBIT) | $-18.64M | $8.38M |
| EBITDA | $-5.59M | $18.95M |
| Pre-Tax Income | $-28.66M | $3.48M |
| Income Tax | N/A | $2.14M |
| Net Income (Profit) | $-28.66M | $1.35M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BBNX | AORT |
|---|---|---|
| Cash & Equivalents | $42.45M | $37.69M |
| Total Current Assets | $261.92M | $287.30M |
| Total Current Liabilities | $16.49M | $51.94M |
| Long-Term Debt | $5.45M | $356.98M |
| Total Shareholders Equity | $313.75M | $294.25M |
| Retained Earnings | $-325.39M | $-61.77M |
| Property, Plant & Equipment | $13.04M | $77.04M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BBNX | AORT |
|---|---|---|
| Operating Cash Flow | $-24.83M | $-17.94M |
| Capital Expenditures | $-333,000 | N/A |
| Free Cash Flow | $-20.31M | $-20.59M |
| Debt Repayment | N/A | $-66,000 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BBNX | AORT |
|---|---|---|
| Shares Short | 3.88M | 1.08M |
| Short Ratio | 5.52 | 2.52 |
| Short % of Float | 0.10% | 0.03% |
| Average Daily Volume (10 Day) | 803,623 | 388,190 |
| Average Daily Volume (90 Day) | 938,151 | 443,357 |
| Shares Outstanding | 42.86M | 41.95M |
| Float Shares | 21.42M | 41.61M |
| % Held by Insiders | 0.01% | 0.05% |
| % Held by Institutions | 1.09% | 0.90% |
Dividend Analysis & Yield Comparison: Beta Bionics vs Artivion
| Metric | BBNX | AORT |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |